Inhibition of Kir2.1 (KCNJ2) by the AMP-activated protein kinase

Ioana Alesutan1, Carlos Munoz, Mentor Sopjani

  • 1Department of Physiology, University of Tübingen, Gmelinstrasse 5, Tübingen, Germany.

Insights

The AMP-activated protein kinase (AMPK) regulates the Kir2.1 potassium channel, impacting cell membrane potential. AMPK reduces Kir2.1 activity and cell membrane levels, partly via Nedd4-2 phosphorylation.

Area of Science:

  • Physiology
  • Molecular Biology
  • Biochemistry

Background:

  • The inward rectifier potassium channel Kir2.1 is crucial for maintaining cell membrane potential in neurons and cardiac myocytes.
  • Mutations in KCNJ2, encoding Kir2.1, cause Andersen-Tawil syndrome, characterized by periodic paralysis, cardiac arrhythmia, and skeletal abnormalities.
  • Ischemia decreases cardiac cell membrane potential and activates AMP-activated serine/threonine protein kinase (AMPK), an energy-sensing kinase.

Purpose of the Study:

  • To investigate whether AMPK regulates the function and abundance of the Kir2.1 channel.
  • To explore the molecular mechanisms underlying AMPK's regulation of Kir2.1.

Main Methods:

  • Xenopus oocytes were injected with cRNA encoding Kir2.1, along with various forms of AMPK or the ubiquitin ligase Nedd4-2.
  • Kir2.1 activity was measured using two-electrode voltage-clamp experiments.
  • Kir2.1 protein levels in the cell membrane were quantified via immunostaining and confocal imaging.

Main Results:

  • Both wild-type and constitutively active AMPK significantly decreased Kir2.1-mediated currents and Kir2.1 protein abundance in the cell membrane.
  • Nedd4-2 expression downregulated Kir2.1 currents, an effect potentiated by co-expressed AMPK.
  • Nedd4-2(S795A), a mutant lacking an AMPK phosphorylation site, showed reduced downregulation of Kir2.1 currents compared to wild-type Nedd4-2 when co-expressed with AMPK.

Conclusions:

  • AMPK is a significant regulator of Kir2.1 channel activity and membrane expression.
  • AMPK's regulatory effect on Kir2.1 is, at least partly, mediated through the phosphorylation of the ubiquitin ligase Nedd4-2.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...